Lite Strategy, Inc. (LITS)
0.9758
0.00 (0.00%)
USD |
NASDAQ |
Aug 31, 16:00
0.9758
0.00 (0.00%)
After-Hours: 20:00
Lite Strategy Cash and Short Term Investments (Quarterly) : 7.544M for March 31, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 7.544M |
| December 31, 2025 | 8.758M |
| September 30, 2025 | 10.11M |
| June 30, 2025 | 18.01M |
| March 31, 2025 | 20.47M |
| December 31, 2024 | 23.74M |
| September 30, 2024 | 26.90M |
| June 30, 2024 | 38.34M |
| March 31, 2024 | 56.55M |
| December 31, 2023 | 59.48M |
| September 30, 2023 | 82.20M |
| June 30, 2023 | 100.69M |
| March 31, 2023 | 112.04M |
| December 31, 2022 | 124.17M |
| September 30, 2022 | 138.37M |
| June 30, 2022 | 153.25M |
| March 31, 2022 | 169.04M |
| December 31, 2021 | 185.75M |
| September 30, 2021 | 145.50M |
| June 30, 2021 | 153.43M |
| March 31, 2021 | 164.62M |
| December 31, 2020 | 180.14M |
| September 30, 2020 | 176.14M |
| June 30, 2020 | 182.63M |
| March 31, 2020 | 92.80M |
| Date | Value |
|---|---|
| December 31, 2019 | 103.88M |
| September 30, 2019 | 65.92M |
| June 30, 2019 | 74.49M |
| March 31, 2019 | 82.29M |
| December 31, 2018 | 93.42M |
| September 30, 2018 | 90.76M |
| June 30, 2018 | 102.74M |
| March 31, 2018 | 36.20M |
| December 31, 2017 | 42.44M |
| September 30, 2017 | 47.02M |
| June 30, 2017 | 53.56M |
| March 31, 2017 | 56.76M |
| December 31, 2016 | 55.15M |
| September 30, 2016 | 58.90M |
| June 30, 2016 | 45.92M |
| March 31, 2016 | 49.40M |
| December 31, 2015 | 53.79M |
| September 30, 2015 | 58.02M |
| June 30, 2015 | 63.78M |
| March 31, 2015 | 70.52M |
| December 31, 2014 | 78.71M |
| September 30, 2014 | 42.06M |
| June 30, 2014 | 48.79M |
| March 31, 2014 | 54.68M |
| December 31, 2013 | 59.76M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| SELLAS Life Sciences Group, Inc. | 138.44M |
| ACADIA Pharmaceuticals, Inc. | 956.47M |
| Alnylam Pharmaceuticals, Inc. | 3.308B |
| Anika Therapeutics, Inc. | 38.41M |
| Savara, Inc. | 173.03M |